Abstract:To study the effect of glucagon-likepeptide 1(GLP-1)receptor agonist on insulin resistance and hepatic oxidative stress in rats with diabetes mellitus combined with nonalcoholic fatty liver disease. 36 male SD rats were served as the experimental animal and randomly divided into control group, model group, and GLP-1 group. The rats of control group were given routine diet with intraperitoneal injection of normal saline, those in model group were given high fat diet and intraperitoneal injection of normal saline, while GLP-1 group rats were fed with high fat diet and intraperitoneal injection of liraglutide. After 4 weeks of treatment, insulin resistance, lipid metabolism, liver injury and oxidative stress were all assessed. Serum fasting blood glucose, fasting insulin, total cholesterol, triglyceride, alanine transaminase(ALT), aspartate transaminase(AST)levels and total cholesterol, triglyceride contents in liver tissue, and as well as homeostasis model assessment for insulin resistance(HOMA-IR)levels of model group were significantly higher than those of control group, complex insulin sensitivity index(ISIcomp)level was significantly lower than that of control group; serum fasting blood glucose, fasting insulin, total cholesterol, triglyceride, ALT, AST contents and HOMA-IR levels of GLP-1 group were significantly lower than those of model group, ISIcomp level was significantly higher than that of model group; superoxide dismutase(SOD), glutathione peroxidase(GSH-Px), catalase(CAT)contents in liver tissue of model group were significantly lower, while malondialdehyde content and SOD, GSH-Px, CAT, NF-E2 related factor-2(Nrf-2), antioxidant response element(ARE), heme oxygenase-1(HO-1), quinone oxidoreductase-1(NQO-1), glutathione thiol transferase(GST)mRNA expression were significantly higher than control group; SOD, GSH-Px, CAT contents and SOD, GSH-Px, CAT, Nrf-2, ARE, HO-1, NQO-1, GST mRNA expression in the liver tissue of GLP-1 group were significantly higher, while malondialdehyde content was significantly lower than that of model group. GLP-1 receptor agonist reduces insulin resistance and liver oxidative stress injury in diabetic rats with nonalcoholic liver disease.

Glucagon-like peptide-1 modulate sucrose solution intake in rats

Sucralose Can Improve Glucose Tolerance and Upregulate Expression of Sweet Taste Receptors and Glucose Transporters in an Obese Rat Model

Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4

Elevation of the Blood Glucose Level is Involved in an Increase in Expression of Sweet Taste Receptors in Taste Buds of Rat Circumvallate Papillae

Sucrose overconsumption impairs AgRP neuron dynamics and promotes palatable food intake

Effect of Sucrose on Glucose and Lipid Metabolism and the Pathological Changes of Liver and Pancreas in GK and Wistar Rats

Synthetic exendin-4 disrupts responding to reward predictive incentive cues in male rats

Comparative Study on Anorexigenic Effect of Glucagon-Like Peptide-1 Receptor Agonists in Rats.

Effect of Sucrose on Pathological Change of Pancreas in GK and Wistar Rats

Secretion Of Gut Hormones And Expression Of Sweet Taste Receptors And Glucose Transporters In A Rat Model Of Obesity

[Sucrose reward promotes rats' motivation for cocaine].

Alterations of sucrose preference and sweet taste sensitivity after short-term high-fat diet feeding in rats

[Μ-Opioid Receptors in the Central Nucleus of the Amygdala Modulate Sucrose Solution Intake in Rats].

Increased Sucrose Intake and Corresponding C-Fos in Amygdala and Parabrachial Nucleus of Dietary Obese Rats

Effect of the Artificial Sweetener, Sucralose, on Gastric Emptying and Incretin Hormone Release in Healthy Subjects.

The GLP-1 Analogue Exenatide Improves Hepatic and Muscle Insulin Sensitivity in Diabetic Rats: Tracer Studies in the Basal State and During Hyperinsulinemic-Euglycemic Clamp.

Effect of Exendin-4 on the Glucose Tolerance and Serum Glucose Level in Normal Animals

Experimental Study on the Glucagon-Likepeptide 1 Receptor Agonist Modulation of Insulin Resistance and Hepatic Oxidative Stress in Rats with Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease

Inhibitory Effects of Peripheral Administration of Exendin-4 on Food Intake Are Attenuated by Lesions of the Central Nucleus of Amygdala.

Effects of Exendin-4 on Glucose and Lipid Metabolism in Diabetic Rats

Dietary protein restriction diminishes sucrose reward and reduces sucrose-evoked mesolimbic dopamine signaling